Michael A. Sullivan

• In 2011, Mr. Sullivan met with the SEC and CFTC Chairmen and senior staff to recommend changes to the proposed rules for SEC and CFTC Whistleblower claims. Since then, he has also represented clients in the SEC Whistleblower and CFTC Whistleblower Programs., 2011
• Mr. Sullivan represented Relators in two of the most significant health care fraud qui tam recoveries in recent years: (1) the $465 million settlement by Mylan, Inc. in 2017 for erroneously classifying its patented, brand name drug EpiPen as a generic drug to avoid its obligation to pay higher Medicaid rebates; and (2) the groundbreaking case that authorized use of statistical sampling to prove elements of FCA liability and damages, United States ex rel. Glenda Martin v. Life Care Centers of America, Inc. (E.D. TN), which in 2016 produced the largest health care fraud settlement in history against a skilled nursing facility chain.
• Mr. Sullivan recently served on the Senior Leadership Team of the Volkswagen AG Monitorship, as counsel to Larry D. Thompson in Mr. Thompson’s role as the Independent Compliance Monitor and Auditor of Volkswagen AG, and as counsel to the VW Monitor Team. Mr. Sullivan’s responsibilities included coordinating with counsel across the globe to ensure compliance  with legal requirements of countries in Europe, Asia, North America, and South America.
• In 2009 and again in 2010, Mr. Sullivan was contacted and consulted by staff members of the U.S. Senate Banking Committee to discuss how the whistleblower provisions of the new "Dodd-Frank" law should be written, and how the new SEC and CFTC Whistleblower Programs should operate.
• Chair, Whistleblower Law Symposium--a national program that addresses latest developments in whistleblower law with leading experts.  Recent topics include fraud in cryptocurrencies/digital currencies, trends in False Claims Act enforcement, and best practices in pursuing claims in the SEC Whistleblower Program, CFTC Whistleblower Program, and IRS Whistleblower Program.  Mr. Sullivan created this program more than ten years ago.

• Mr. Sullivan was lead counsel in the trial of a commercial kickback case, and won a seven-figure jury verdict against dishonest executives who had defrauded his client, a major international corporation.  This was one of various seven-figure jury verdicts Mr. Sullivan has won at trial for his clients., 2014
• Mr. Sullivan represented Relators in two of the most significant health care fraud qui tam recoveries in recent years: (1) the $465 million settlement by Mylan, Inc. in 2017 for erroneously classifying its patented, brand name drug EpiPen as a generic drug to avoid its obligation to pay higher Medicaid rebates; and (2) the groundbreaking case that authorized use of statistical sampling to prove elements of FCA liability and damages, United States ex rel. Glenda Martin v. Life Care Centers of America, Inc. (E.D. TN), which in 2016 produced the largest health care fraud settlement in history against a skilled nursing facility chain., 2017

• Mr. Sullivan represented whistleblowers in SEC whistleblower and IRS whistleblower claims, as well as lead counsel in False Claims Act litigation regarding health care fraud., 2022
• Mr. Sullivan conducted an internal investigation of a publicly traded company on behalf of a Special Committee of the Board of Directors.  This was one of several internal investigations for various businesses., 2021
• Mr. Sullivan served on the Senior Leadership Team of the Volkswagen AG Monitorship, as counsel to Larry D. Thompson in Mr. Thompson’s role as the Independent Compliance Monitor and Auditor of Volkswagen AG, and as counsel to the VW Monitor Team. Mr. Sullivan’s responsibilities included coordinating with counsel across the globe to comply with legal requirements of countries in Europe, Asia, North America, and South America., 2020

• Mr. Sullivan was part of a pro bono effort that uncovered falsified evidence used to convict a man of murder and send him to  Death Row.  Based on evidence Mr. Sullivan helped uncover, the conviction was reversed, and the client was freed.  ofNelson v. Zant, 261 Ga. 358, 405 S.E.2d 250 (1991), 1991

• Senior Articles Editor, Vanderbilt Law Review, Vanderbilt University Law School

• University of North Carolina

• Regularly updated summary of the False Claims Act., Author, “The Federal False Claims Act and Georgia's Two State False Claims Acts” (2007-2019)., 2022

• CFTC Whistleblower Claims
• Complex Business Litigation
• False Claims Act (Qui Tam) Litigation
• IRS Whistleblower claims
• SEC Whistleblower Claims

“Experienced White Collar Criminal defender and outstanding performance in internal investigations.”

“An absolutely superb lawyer on any kind of civil case.”

“Exceptional lawyer”